What is the optimal first-line treatment for children with chronic inflammatory deruyelinating polyneu-ropathy (CIDP)? It is doubtful that a broadly accepted, evidence-based answer to this question will emerge from this discussion. In addition to the relatively straightforward scientific issues, ...
The disease progressively worsens over one’s lifetime, there is currently no treatment, the disease can’t be cured, and it affects everybody very differently from one another.” Sometimes, people will ask follow-up questions. Other times, we part ways with only a, “whoa,” and maybe th...
various forms of connective tissue disorders (eg, lupus, Sjogren's syndrome), and neuropathies associatedwith nutritional deficiencies or toxin exposure, which may complicate diagnosis.2,4 For example, in patients with dia- betes, CIDP must be distinguished from diabetic neuropa- thy and neuropathy...